Ruth Jimbo-Sotomayor

Dr. Ruth Jimbo-Sotomayor

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2019 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
HFHeidi Fernandez
Heidi Fernandez
ACAndrea Cevallos
Andrea Cevallos
RJRuth Jimbo-Sotomayor
Ruth Jimbo-Sotomayor
FNFernando Naranjo-Saltos
Fernando Naranjo-Saltos
DODiego Mera Orces
Diego Mera Orces
EBEfrain Basantes
Efrain Basantes

27 July 2018 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
XSXavier Sanchez
Xavier Sanchez
MAMaría Luciana Armijos Acurio
María Luciana Armijos Acurio
RJRuth Jimbo-Sotomayor
Ruth Jimbo-Sotomayor
Upper respiratory tract infections are the leading cause of misuse of antibiotics, a problem that leads to unnecessary adverse events and antibiotic resistance. Antibiotic prescription in Ecuador was analyzed in order to evaluate the state of antibiotic prescribing for upper respiratory tract infections. Both the appropriateness and adequacy of prescribing was evaluated. Appropriateness represents the percentage of prescriptions that are indicated; adequacy refers to the percentage of patients requiring antibiotics who are treated. The aim of the study is to analyze the appropriateness and adequacy of antibiotic prescription for upper respiratory tract infections in the Ambulatory Health Centers of the Ministry of Public Health of Ecuador. This is a cross-sectional study of patients from one Health Center of the Ministry of Public Health in the District 17D03 in Ecuador during 2015 with upper respiratory tract infection as a primary diagnosis. We included a total of 1393 patients in the analysis. Out of the 1393 patients identified, 523 were prescribed antibiotics, constituting an antibiotic prescription rate of 37.5%, and 51 required antibiotics, reflecting a real need of antibiotics of 3.7%. Appropriateness: Of these 523 patients who were treated, 51 required an antibiotic, resulting in an appropriate antibiotic prescription rate of 9.75%. Adequacy: When analyzing each individual case, 33 of these 51 patients received an antibiotic, constituting an adequate prescription rate of 64.7%. The results of our study report a 90.25% of inappropriate prescription. The antibiotic prescription, appropriate prescription, and adequate prescription rates show the need for implementation of strategies in order to reduce them. Related aspects regarding prescriber’s behavior and the patient’s expectations should be analyzed.

1 October 2020 in Vaccine
Verified
Journal Article
Closed access
RJRuth Jimbo-Sotomayor
Ruth Jimbo-Sotomayor
CTCristiana M. Toscano
Cristiana M. Toscano
XCXavier Sánchez Choez
Xavier Sánchez Choez
MOMartín Vilema Ortíz
Martín Vilema Ortíz
JCJackson Rivas Condo
Jackson Rivas Condo
LOLucia H. de Oliveira
Lucia H. de Oliveira

30 June 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
EOEsteban Ortiz-Prado
Esteban Ortiz-Prado
Juan S. Izquierdo-CondoyJuan S. Izquierdo-Condoy
Juan S. Izquierdo-Condoy
RFRaul Fernandez-Naranjo
Raul Fernandez-Naranjo
KSKatherine Simbaña-Rivera
Katherine Simbaña-Rivera
JVJorge Vasconez
Jorge Vasconez
RJRuth Jimbo-Sotomayor
Ruth Jimbo-Sotomayor
The COVID-19 pandemic has put a lot of pressure on health systems worldwide. Mass vaccination against SARS-CoV-2 has reduced morbidity and mortality worldwide. Despite their safety profiles, vaccines, as with any other medical product, can cause adverse events. Yet, in countries with poor epidemiological surveillance and monitoring systems, reporting vaccine-related adverse events is a challenge. The objective of this study was to describe self-reported vaccine adverse events after receiving one of the available COVID-19 vaccine schemes in Ecuador. A cross-sectional analysis based on an online, self-reported, 32-item questionnaire was conducted in Ecuador from 1 April to 15 July 2021. Participants were invited by social media, radio, and TV to voluntarily participate in our study. A total of 6654 participants were included in this study. Furthermore, 38.2% of the participants reported having at least one comorbidity. Patients received AstraZeneca, Pfizer, and Sinovac vaccines, and these were distributed 38.4%, 31.1%, and 30.5%, respectively. Overall, pain or swelling at the injection site 17.2% (n = 4500) and headache 13.3% (n = 3502) were the most reported adverse events. Women addressed events supposedly attributable to vaccination or immunization [ESAVIs] (66.7%), more often than men (33.2%). After receiving the first dose of any available COVID-19 vaccine, a total of 19,501 self-reported ESAVIs were informed (87.0% were mild, 11.5% moderate, and 1.5% severe). In terms of the vaccine type and brand, the most reactogenic vaccine was AstraZeneca with 57.8%, followed by Pfizer (24.9%) and Sinovac (17.3%). After the second dose, 6776 self-reported ESAVIs were reported (87.1% mild, 10.9% moderate, and 2.1% severe). AstraZeneca vaccine users reported a higher proportion of ESAVIs (72.2%) in comparison to Pfizer/BioNTech (15.9%) and Sinovac Vaccine (11.9%). Swelling at the injection site, headache, muscle pain, and fatigue were the most common ESAVIs for the first as well as second doses. In conclusion, most ESAVIs were mild. AstraZeneca users were more likely to report adverse events. Participants without a history of COVID-19 infection, as well as those who received the first dose, were more prone to report ESAVIs.

1 January 2020 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
PDF file
XSXavier Sanchez
Xavier Sanchez
ALAndrea Landázuri
Andrea Landázuri
PLPaulina Londo
Paulina Londo
AMAndrea Manzano
Andrea Manzano
ARAndrés Moreno Roca
Andrés Moreno Roca
RJRuth Jimbo-Sotomayor
Ruth Jimbo-Sotomayor
Inappropriate prescriptions of antibiotics lead to ineffective and unsafe treatments and worsening of diseases. Medical students may have deficiencies in their prescription skills and they may need further training in the use of antibiotics for their practice. Medical skills in prescribing antibiotics can be improved through continuous medical education. The aim of this study was to assess the current levels of knowledge, attitudes, and practices (KAP) in antibiotic prescription in upper respiratory tract infections (URTI) among postgraduate family medicine students in Ecuador. A cross-sectional study with an on-line survey, based on micro-curricular contents, to evaluate KAPs regarding antibiotic prescription in URTI among postgraduate family medicine students in 5 provinces of Ecuador. Two hundred and seventy-three physicians responded (94.1%). Most physicians treated between 1 and 5 URTI cases per day. The odds for inadequate knowledge and inappropriate practices in URTI among postgraduate family medicine students were 8.74 (95%CI, 4.94-15.46, P < .001) and 5.99, (IC95%, 2.66-13.50, P < .001) in physicians who were students of the first half of the study program. The knowledge in URTI was limited among physicians. Nonetheless, they expressed a positive attitude toward not using antibiotics in URTI. A postgraduate program can significantly improve the knowledge and practices related to antibiotic prescriptions in URTI.

30 November 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XSXavier Sanchez
Xavier Sanchez
ALAlicia Latacunga
Alicia Latacunga
ICIván Cárdenas
Iván Cárdenas
RJRuth Jimbo-Sotomayor
Ruth Jimbo-Sotomayor
SESantiago Escalante
Santiago Escalante
Background: Urinary tract infections (UTI) are among the most common cause to prescribe antibiotics in primary care. Diagnosis is based on the presence of clinical symptoms in combination with the results of laboratory tests. Antibiotic therapy is the primary approach to the treatment of UTIs; however, some studies indicate that therapeutics in UTIs may be suboptimal, potentially leading to therapeutic failure and increased bacterial resistance. Methods: This study aimed to analyze the antibiotic prescription patterns in adult patients with suspected UTIs and to evaluate the appropriateness of the antibiotic prescription. This is a cross-sectional study of patients treated in outpatient centers and in a second-level hospital of the Ministry of Public Health (MOPH) in a city in Ecuador during 2019. The International Classification of Disease Tenth Revision (ICD-10) was used for the selection of the acute UTI cases. The patients included in this study were those treated by family, emergency, and internal medicine physicians. Results: We included a total of 507 patients in the analysis and 502 were prescribed antibiotics at first contact, constituting an immediate antibiotic prescription rate of 99.01%. Appropriate criteria for antibiotic prescription were met in 284 patients, representing an appropriate prescription rate of 56.02%. Less than 10% of patients with UTI had a urine culture. The most frequently prescribed antibiotics were alternative antibiotics (also known as second-line antibiotics), such as ciprofloxacin (50.39%) and cephalexin (23.55%). Factors associated with inappropriate antibiotic prescribing for UTIs were physician age over forty years, OR: 2.87 (95% CI, 1.65–5.12) p<0.0001, medical care by a general practitioner, OR: 1.89 (95% CI, 1.20–2.99) p = 0.006, not using point-of-care testing, OR: 1.96 (95% CI, 1.23–3.15) p = 0.005, and care at the first level of health, OR: 15.72 (95% CI, 8.57–30.88) p<0.0001. Conclusions: The results of our study indicate an appropriate prescription rate of 56.02%. Recommended antibiotics such as nitrofurantoin and fosfomycin for UTIs are underutilized. The odds for inappropriate antibiotic prescription were 15.72 times higher at the first level of care compared to the second. Effective strategies are needed to improve the diagnosis and treatment of UTIs.